{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:04:26Z","timestamp":1792807466556,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.vaccine.2005.07.111","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T13:03:42Z","timestamp":1127221422000},"page":"3804-3811","source":"Crossref","is-referenced-by-count":135,"title":["Vaccines against typhoid fever"],"prefix":"10.1016","volume":"24","author":[{"given":"Carlos A.","family":"Guzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Borsutzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Griot-Wenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Pearman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Collioud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Favre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.07.111_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0966-842X(01)02067-4","article-title":"The molecular mechanisms of severe typhoid fever","volume":"9","author":"Everest","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.111_bib2","series-title":"Vaccines","first-page":"781","article-title":"Typhoid fever vaccines","author":"Levine","year":"1999"},{"key":"10.1016\/j.vaccine.2005.07.111_bib3","first-page":"957","article-title":"Vaccination against typhoid fever: present status","volume":"72","author":"Ivanoff","year":"1994","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2005.07.111_bib4","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.07.111_bib5","first-page":"508","article-title":"Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. I. Measurements of serum antibodies by radioimmunoassay","volume":"46","author":"Tsang RSW","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2005.07.111_bib6","first-page":"115","article-title":"Specific immune responses in typhoid fever & after TAB vaccination","volume":"91","author":"Bhaskaram","year":"1990","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2005.07.111_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1099\/00222615-44-5-317","article-title":"Multi-drug resistant typhoid: a global problem","volume":"44","author":"Mirza","year":"1996","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.111_bib8","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.283.20.2668","article-title":"Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise","volume":"283","author":"Ackers","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.111_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2105\/AJPH.75.1.71","article-title":"An analysis of economic costs associated with an outbreak of typhoid fever","volume":"75","author":"Shandera","year":"1985","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2005.07.111_bib10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(67)90335-2","article-title":"A seven-year field trial of two typhoid vaccines in Guyana","volume":"2","author":"Ashcroft","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.111_bib11","first-page":"321","article-title":"A controlled field trial and laboratory study of five typhoid vaccines in the USSR","volume":"34","author":"Hejfec","year":"1966","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2005.07.111_bib12","first-page":"75","article-title":"Controlled field trial on the effectiveness of one and two doses of acetone-inactivated and dried typhoid vaccine","volume":"52","author":"Tapa","year":"1975","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2005.07.111_bib13","first-page":"196","article-title":"Controlled field trial in British Guyana school-children of heat-killed phenolized and acetone-killed lyophilized typhoid vaccines","volume":"79","author":"Ashcroft","year":"1964","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2005.07.111_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bmj.316.7125.110","article-title":"Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity","volume":"316","author":"Engels","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2005.07.111_bib15","first-page":"506","article-title":"Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro","volume":"108","author":"Looney","year":"1986","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.vaccine.2005.07.111_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/150.3.436","article-title":"Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi","volume":"150","author":"Robbins","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib17","first-page":"52","article-title":"Studies on Vi antigen. Immunization of human beings with purified Vi antigen","volume":"60","author":"Landy","year":"1954","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2005.07.111_bib18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/infdis\/125.4.360","article-title":"Effect of a Vi-degrading enzyme on the potency of typhoid vaccines in mice","volume":"125","author":"Wong","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/IAI.9.2.348-353.1974","article-title":"Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals","volume":"9","author":"Wong","year":"1974","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s100960050361","article-title":"Experience with Salmonella typhi Vi capsular polysaccharide vaccine","volume":"18","author":"Hessel","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report","volume":"317","author":"Acharya","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.07.111_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"2","author":"Klugman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.111_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/infdis\/154.2.342","article-title":"Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines","volume":"154","author":"Tacket","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib25","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1001\/archinte.155.21.2293","article-title":"A new typhoid vaccine composed of the Vi capsular polysaccharide","volume":"155","author":"Plotkin","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2005.07.111_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.07.111_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(92)90021-B","article-title":"The mucosal immune system: from fundamental concepts to vaccine development","volume":"10","author":"McGhee","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1357-4310(99)01633-0","article-title":"Recent advances with recombinant bacterial vaccine vectors","volume":"6","author":"Shata","year":"2000","journal-title":"Mol Med Today"},{"key":"10.1016\/j.vaccine.2005.07.111_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm0103-99","article-title":"Can needle-free administration of vaccines become the norm in global immunization?","volume":"9","author":"Levine","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2005.07.111_bib31","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2003.12.033","article-title":"Genetic aspects relevant to the biosafety of the recombinant live oral Vibrio cholerae strain CVD103-HgR","volume":"22","author":"Viret","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/infdis\/133.4.424","article-title":"Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization","volume":"133","author":"Levine","year":"1976","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","article-title":"Isolation and characterisation of Gal E mutant Ty21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine","volume":"131","author":"Germanier","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib34","first-page":"349","article-title":"Attenuated, live, oral typhoid vaccine","volume":"24","author":"Cryz","year":"1988","journal-title":"Drugs Today"},{"key":"10.1016\/j.vaccine.2005.07.111_bib35","first-page":"3","article-title":"Characteristics of the attenuated oral vaccine strain \u201cS. typhi\u201d Ty21a","volume":"53","author":"Germanier","year":"1983","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2005.07.111_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2958.1996.tb02664.x","article-title":"Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (\u03c3S) regulon","volume":"22","author":"Coynault","year":"1996","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.111_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1574-6968.1995.tb07412.x","article-title":"The live oral typhoid vaccine Ty21a is a rpoS mutant and is susceptible to various environmental stresses","volume":"126","author":"Robbe-Saule","year":"1995","journal-title":"FEMS Microbiol Lett"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2005.07.111_bib38","doi-asserted-by":"crossref","first-page":"S552","DOI":"10.1093\/clinids\/11.Supplement_3.S552","article-title":"Progress in vaccines against typhoid fever","volume":"11","author":"Levine","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0264-410X(02)00579-0","article-title":"Experience with registered mucosal vaccines","volume":"21","author":"Dietrich","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib40","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.4049\/jimmunol.169.4.2196","article-title":"Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain Ty21a typhoid vaccine","volume":"169","author":"Salerno-Goncalves","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.111_bib41","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/IAI.67.7.3680-3685.1999","article-title":"Mucosal and systemic immune responses in humans after primary and booster immunisations with orally administered invasive and non-invasive live attenuated bacteria","volume":"67","author":"Viret","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0264-410X(93)90237-R","article-title":"Clinical and immunologic response to typhoid vaccination in two groups of 30 recruits","volume":"11","author":"Nisini","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/BC.2001.066","article-title":"Intracellular bacteria as targets and carriers for vaccination","volume":"382","author":"Mollenkopf","year":"2001","journal-title":"Biol Chem"},{"key":"10.1016\/j.vaccine.2005.07.111_bib44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0140-6736(90)92266-K","article-title":"Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial","volume":"336","author":"Levine","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.111_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0264-410X(90)90183-M","article-title":"Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee","volume":"8","author":"Black","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","article-title":"Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area","volume":"159","author":"Ferreccio","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib47","unstructured":"Advisory Committee on Immunisation Practices. Recommendations of the Advisory Committee on Immunisation Practices (ACIP): Typhoid Immunisation. MMWR 1994;43(RR-14)."},{"key":"10.1016\/j.vaccine.2005.07.111_bib48","first-page":"104","article-title":"Excellent long-term safety data established in a recent post-marketing surveillance for the oral typhoid fever vaccine, VIVOTIF\u00ae","volume":"6","author":"Griot-Wenk","year":"2001","journal-title":"Ital J Trop Med"},{"key":"10.1016\/j.vaccine.2005.07.111_bib49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/infdis\/136.6.717","article-title":"Evaluation of a UDP-glucose-4-epimerase-less mutant of Salmonella typhi as a live oral vaccine","volume":"136","author":"Gilman","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib50","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1128\/IAI.56.5.1326-1333.1988","article-title":"A galE via (Vi-antigen negative) mutant of Salmonelly typhi Ty2 retains virulence in humans","volume":"56","author":"Hone","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib51","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S1286-4579(01)01487-3","article-title":"Host-Salmonella interaction: human trials","volume":"3","author":"Levine","year":"2001","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2005.07.111_bib52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/infdis\/145.3.292","article-title":"A controlled field trial of Live Salmonella typhi strain Ty21a oral vaccine against typhoid: three-year results","volume":"145","author":"Wahdan","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib53","first-page":"9","article-title":"Immunogenicity of Ty21a attenuated Salmonella typhi given with sodium bicarbonate or in enteric-coated capsules","volume":"53","author":"Black","year":"1983","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2005.07.111_bib54","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.267.8.1074","article-title":"Compliance with live, oral Ty21a vaccine","volume":"267","author":"Kaplan","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.07.111_bib55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0264-410X(92)90392-W","article-title":"Clinical acceptability and immunogenicity of CVD908 Salmonella typhi vaccine strain","volume":"10","author":"Tacket","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib56","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0264-410X(99)00424-7","article-title":"Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity","volume":"18","author":"Dilts","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib57","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1128\/IAI.67.2.700-707.1999","article-title":"Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA","volume":"67","author":"Lowe","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib58","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/IAI.65.2.452-456.1997","article-title":"Safety of live oral Salmonella typhi vaccine strains harbouring defined mutations in htrA and aroC, aroD and immune response in humans","volume":"65","author":"Tacket","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib59","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib60","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/173.6.1408","article-title":"PhoP\/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in adult volunteers","volume":"173","author":"Hohmann","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib61","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1128\/IAI.55.12.3035-3043.1987","article-title":"Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic","volume":"55","author":"Curtiss","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib62","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.65.8.3381-3385.1997","article-title":"Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system","volume":"65","author":"Tacket","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib63","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssvA) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib64","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1128\/IAI.68.8.4647-4652.2000","article-title":"Constitutive expression of the vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar Typhi oral vaccine strain CVD909","volume":"68","author":"Wang","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.111_bib65","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/421469","article-title":"Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide","volume":"190","author":"Tacket","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.111_bib66","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/0264-410X(96)81276-X","article-title":"Urgent need for effective vaccine against Salmonella paratyphi A, B, and C","volume":"13","author":"Arya","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.111_bib67","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1742-1241.1996.tb09609.x","article-title":"Limitations of typhoid vaccination for travellers","volume":"50","author":"Stephen","year":"1996","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.vaccine.2005.07.111_bib68","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Chilean Typhoid Committee. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation","volume":"1","author":"Levine","year":"1987","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05006766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05006766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T16:53:53Z","timestamp":1683219233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05006766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":68,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0264410X05006766"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.111","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}